NGNENeurogene Inc.
$26.44+13% 1Y
$26.44
$16.3752 weeks$42.88
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Rangebound, no clear trend. Oversold (RSI 29). Price is −3% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How NGNE is trading
Neurogene Inc. is +13% over the past year while the S&P 500 is +18%: 5.6 points behind the market.
+13%
1-year return · S&P 500 +18%
- vs 200-day average
- −3.3%
vs 200-day average · below trend, but not far
- RSI (14)
- 29
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 38%
Below its 52-week high
Details›
- Last close2026-10-08
- $26.44
- 1 monthS&P 500 +1.6%
- −30%
- 1 yearS&P 500 +18%
- +13%
- 5 yearsS&P 500 +86%
- −82%
- vs 50-day average$34.08
- −22%
- 52-week high
- $42.88
- 52-week low
- $16.37
- Annualised volatility
- 110%
| Year | Return |
|---|---|
| 2026 (year to date) | +28% |
| 2025 | −9.9% |
| 2024 | +18% |
| 2023 | +90% |
| 2022 | −89% |
| 2021 | −66% |
| 2020 | +14% |
| 2019 | +470% |
| 2018 | −82% |
| 2017 | −29% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +1.7% |
| Feb | 10 | 5 of 10 | +0.10% |
| Mar | 10 | 5 of 10 | +4.3% |
| Apr | 10 | 4 of 10 | −0.92% |
| May | 10 | 5 of 10 | −0.55% |
| Jun | 10 | 5 of 10 | −5.1% |
| Jul | 11 | 7 of 11 | +2.7% |
| Aug | 11 | 9 of 11 | +9.7% |
| Sep | 11 | 3 of 11 | −5.9% |
| Oct | 11 | 4 of 11 | +1.0% |
| Nov | 10 | 4 of 10 | +1.1% |
| Dec | 10 | 5 of 10 | +17% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.